Description

GLP-R is 300mg as 10 vials of 30mg; an investigational once‑weekly injectable that activates three metabolic hormone receptors (GLP‑1, GIP, and glucagon) to support research into weight‑related metabolic pathways. It is not FDA‑approved, not available for purchase, and is currently being evaluated in Phase 3 clinical trials.